Research have considered that ceramide can inhibit protein kinase B (PKB/Akt) and the membrane translocation of glucose transporter (GLUT), suppressing the secretion of insulin and worsening glucose metabolism that favors the development of insulin resistance (IR) and, therefore, liver function deteriorates [9,12]. This evidence concerns the gene AKT1 and Insulin resistance.